Head to head
Rapid7 vs Microsoft
Side-by-side on the measures that matter, with a plain-English read. Full detail: RPD · MSFT
RPD
Rapid7
12.76+2.12%
1-year price shape — -30% over the period
Quant Rating D · 43/100
vs
MSFT
Microsoft
532.15+0.45%
1-year price shape — +2% over the period
Quant Rating C · 40/100
1-year performance, rebased to 100
Microsoft edges it on the scoreable measures. Microsoft has done best over the past year (+2%); Microsoft trades cheapest on trailing earnings; Microsoft pays the highest dividend yield.
| RPD | MSFT | |
|---|---|---|
| Snapshot | ||
| Sector | Software - Infrastructure | Software - Infrastructure |
| Last price | 12.76 | 532.15 |
| Change today | +2.12% | +0.45% |
| 1-year return | -29.7% | +1.9% |
| Market cap | $859.70M | $3.95T |
| 52-week range | 4.97 – 19.84 | 348.54 – 549.20 |
| Valuation | ||
| P/E (TTM) | 41.15 | 29.64 |
| P/E percentile, own 5-yr range | 79th | 30th |
| P/B | 4.37 | 8.93 |
| Dividend yield | 0.00% | 0.67% |
| Profitability & growth | ||
| EPS (TTM) | 0.36 | 17.95 |
| Net profit (TTM) | $24.26M | $133.29B |
| Revenue (TTM) | $855.92M | $331.84B |
| Revenue growth (YoY) | -1.5% | +17.7% |
| Gross margin | 69.3% | 67.9% |
| Operating margin | 1.4% | 46.8% |
| Net margin | 2.4% | 40.3% |
| Free cash flow (TTM) | $128.51M | $66.99B |
| Ownership & sentiment | ||
| Institutional ownership | 104.1% | 75.3% |
| Insider activity (12mo) | 26 buy / 21 sell | 31 buy / 16 sell |
| Short interest (% of float) | 11.5% | 0.9% |
| Analyst consensus | 7% buy / 71% hold / 21% sell (14) | 100% buy (32) |
| Analyst price target | $12 (-6%) | $582 (+9%) |
| StockVane view | ||
| StockVane Quant Rating | D (43) | C (40) |
| Company | ||
| Employees | 2,613 | 223,000 |
| Founded | 2000 | 1975 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.